Kimberly Wirth, DVM, DACVIM (Oncology)Board Certified Oncologist

    Dr. Wirth received her DVM from the University of Wisconsin-Madison School of Veterinary Medicine. She also has a BS in Zoology from the University of Wisconsin-Madison.

    • Intern, Southern Arizona Veterinary Specialty and Emergency Center, Tucson, AZ, 2009-2010
    • Intern, Oncology Clinical Trials, University of Wisconsin-Madison School of Veterinary Medicine, Madison, WI, 2010-2011
    • Resident, University of Florida College of Veterinary Medicine, Gainesville, FL, 2011-2014

    On what she enjoys most about working at WVRC…“Animals positively enhance our lives, and they are able to bring out some of the best qualities in people. I realized that I wanted to care for animals, and the most logical way to do this was to become a veterinarian. Being able to offer treatment options, whether curative or palliative, for a different kind of chronic disease (cancer) is important to me. We should continue the fight against cancer while allowing patients to maintain a good quality of life.”


    American College of Veterinary Internal Medicine
    American Veterinary Medical Association
    Veterinary Cancer Society

    Professional Interests:

    Dr. Wirth’s professional interests include improvement of diagnosis and treatment of canine hemangiosarcoma and feline/canine oral squamous cell carcinoma. She also has an interest in the combination of Western veterinary medicine and traditional Chinese veterinary medicine.

    Research & Publications:

    1. Wirth K, Kow K, Milner R, Bacon N, Salute M. In vitro effects of Yunnan Baiyao on canine hemangiosarcoma cell lines. Vet Comp Oncol; 2014 Jun 29. [Epub ahead of print].

    2. Kubicek L, Vanderhart D, Wirth K, An Q, Chang M, et al. Association between computed tomographic characteristics and fractures following stereotactic radiosurgery in dogs with appendicular osteosarcoma. Vet Radiol Ultrasound; 2016 May; 57(3): 321-30.

    3. Speas A, Lyles S, Wirth K, Fahey C, Kow K. Ammonia levels after L-asparaginase therapy in 27 dogs with high-grade lymphoma or leukemia. Accepted to JVECC 2015 Dec.

    Start typing and press Enter to search

    Cassandra Williams, DVM, DACVIM (Neurology) Board Certified NeurologistWhitney Miesbauer, DVM Emergency Service